↓ Skip to main content

American Association for Cancer Research

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas

Overview of attention for article published in Molecular Cancer Therapeutics, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#43 of 3,889)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
11 news outlets
blogs
1 blog
twitter
11 X users

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
63 Mendeley